Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)
Condition: Peritoneal Metastases From Colorectal Cancer Intervention: Procedure: Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC) Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Peritoneal Cancer | Research